Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Otsuka joins its Japanese peers on Twitter

The firm's US operations make their social media debut

Otsuka's US operations have joined Twitter, catching up with many of their Japanese peers.

Taking a practical approach to potential pitfalls with the medium the firm has compiled a straightforward set of Twitter guidelines and used as its pinned tweet details of how to report side effects.

Many of Otsuka's fellow Japanese pharma companies have been using Twitter for some time, with Daiichi Sankyo making the most extensive use with seven accounts, including ones for Europe, Spain and Brazil.

Astellas also makes wide use of the social media platform, with accounts that include its US corporate operations, a publications-based account and one for the cycling team it sponsors.

Takeda, meanwhile, is rather more focused, opting for a corporate account and one for the corporate communications team of its US oncology operations.

Some of the main Japanese pharma companies on Twitter

@AstellasUS
@AstellasPubs
@astellascycling
@AstellasINNOV8
@AstellasFDN
@AstellasCZ

@EUdaiichisankyo
@DaiichiSankyoES
@DaiichiSankyoJP
@DaiichiSankyoBr
@DaiichiSankyo
@DaiichiSankyoUK [Tweets protected]

@OtsukaUS

@TakedaPharma
@TakedaOncology

25th May 2016

From: Marketing

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Springer Nature

Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....